regadenoson has been researched along with Primary Graft Dysfunction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bromberger, B; Brzezinski, M; Calabrese, DR; Kukreja, J | 1 |
| Shaver, CM | 1 |
2 other study(ies) available for regadenoson and Primary Graft Dysfunction
| Article | Year |
|---|---|
Regadenoson Is All the RAGE: Targeting the Inflammatory Cascade in Primary Graft Dysfunction.
Topics: Coronary Artery Disease; Humans; Primary Graft Dysfunction; Purines; Vasodilator Agents | 2023 |
Regadenoson to the rescue: On the road toward prevention of primary graft dysfunction after lung transplantation.
Topics: Adenosine A2 Receptor Agonists; Humans; Lung Transplantation; Primary Graft Dysfunction; Purines; Pyrazoles; Receptor, Adenosine A2A | 2020 |